1. Academic Validation
  2. Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments

Paneth cell α-defensins HD-5 and HD-6 display differential degradation into active antimicrobial fragments

  • Proc Natl Acad Sci U S A. 2019 Feb 26;116(9):3746-3751. doi: 10.1073/pnas.1817376116.
D Ehmann 1 J Wendler 1 L Koeninger 1 I S Larsen 2 3 T Klag 1 J Berger 4 A Marette 2 3 M Schaller 5 E F Stange 1 N P Malek 1 B A H Jensen 2 3 6 J Wehkamp 7
Affiliations

Affiliations

  • 1 Internal Medicine I, University Hospital Tübingen, 72076 Tübingen, Germany.
  • 2 Quebec Heart and Lung Institute, Department of Medicine, Faculty of Medicine, Cardiology Axis, Laval University, G1V 4G5 Quebec, QC, Canada.
  • 3 Institute of Nutrition and Functional Foods, Laval University, G1V 4G5 Quebec, QC, Canada.
  • 4 Electron Microscopy Unit, Max-Planck-Institute for Developmental Biology, 72076 Tübingen, Germany.
  • 5 Department of Dermatology, University Hospital Tübingen, 72076 Tübingen, Germany.
  • 6 Novo Nordisk Foundation Center for Basic Metabolic Research, Section for Metabolic Genomics, Faculty of Health and Medical Sciences, University of Copenhagen, 1165 Copenhagen, Denmark.
  • 7 Internal Medicine I, University Hospital Tübingen, 72076 Tübingen, Germany; [email protected].
Abstract

Antimicrobial Peptides, in particular α-defensins expressed by Paneth cells, control microbiota composition and play a key role in intestinal barrier function and homeostasis. Dynamic conditions in the local microenvironment, such as pH and redox potential, significantly affect the antimicrobial spectrum. In contrast to oxidized Peptides, some reduced defensins exhibit increased vulnerability to proteolytic degradation. In this report, we investigated the susceptibility of Paneth-cell-specific human α-defensin 5 (HD-5) and -6 (HD-6) to intestinal proteases using natural human duodenal fluid. We systematically assessed proteolytic degradation using liquid chromatography-mass spectrometry and identified several active defensin fragments capable of impacting Bacterial growth of both commensal and pathogenic origins. Of note, incubation of mucus with HD-5 resulted in 255-8,000 new antimicrobial combinations. In contrast, HD-6 remained stable with consistent preserved nanonet formation. In vivo studies demonstrated proof of concept that a HD-5 fragment shifted microbiota composition (e.g., increases of Akkermansia sp.) without decreasing diversity. Our data support the concept that secretion of host Peptides results in an environmentally dependent increase of antimicrobial defense by clustering in active peptide fragments. This complex clustering mechanism dramatically increases the host's ability to control pathogens and commensals. These findings broaden our understanding of host modulation of the microbiome as well as the complexity of human mucosal defense mechanisms, thus providing promising avenues to explore for drug development.

Keywords

antimicrobial peptides; host–microbiota interaction; intestinal barrier; proteolytic digestion; α-defensins.

Figures